The effect of Curcumin on serum lipid profiles and systemic inflammation in hemodialysis patients
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedHemodialyzied kidney desease patients.
- Registration Number
- IRCT2017022232719N1
- Lead Sponsor
- Vice chancellor for research,Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
I The patient's tendency to participating in study and signing approval form? Having a history of at least 6 months of dialysis? age between 25-75 years old ? BMI between 18.5 to 30? Lack of infectious disease, particularly hepatitis? Avoiding the use of no steroidal anti-inflammatory drugs, Nicotinic Acid, estrogen, progesterone and Curcumin supplementation for at least one month before the start of the study? Lack of drug addiction? Lack of severe heart disease, liver failure and thyroid, severe gastrointestinal bleeding and peptic ulcer disease, cholelithiasis, pregnancy or lactation Exclusion criteria: Increasing of potassium in patients' blood during the study? unwilling to continue to participate?Death of the patient? Performing kidney transplantation? Increasing in dose of anti-fat drugs? Changing patient's lifestyle or diet during the study? The use of herbal medicines for lipid lowering during the study? No adherence to study intervention of at least 9 tablets during two months of interference
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Trigliceride? Cholestrol? LDL? HDL ? hs crp. Timepoint: Before entrances and after entrances. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method BUN? Cr? Serum Albumin ? Adequacy of Dialysis ? BMI. Timepoint: Before entrances and after entrance. Method of measurement: Blood test.